Chimeric Therapeutics Ltd banner

Chimeric Therapeutics Ltd
ASX:CHM

Watchlist Manager
Chimeric Therapeutics Ltd Logo
Chimeric Therapeutics Ltd
ASX:CHM
Watchlist
Price: 0.165 AUD -17.5% Market Closed
Market Cap: AU$8.6m

Intrinsic Value

The intrinsic value for Chimeric Therapeutics Ltd (CHM) under the Base Case is 0.985 AUD. Compared with the current market price of 0.165 AUD, the stock appears Undervalued by 83%.

CHM Intrinsic Value
0.985 AUD
Why this value?
Undervaluation 83%
Intrinsic Value
Price AU$0.165
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value AU$0.79
Get notified when the price drops into your buy zone
Intrinsic Value AU$0.99
Margin of Safety 20% AU$0.79
Current Price AU$0.17
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about CHM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CHM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Chimeric Therapeutics Ltd.

Explain Valuation
Alternatives to CHM

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Chimeric Therapeutics Ltd

Efficiency

Earnings Waterfall
Chimeric Therapeutics Ltd

Wall St
Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one CHM stock?

The intrinsic value for Chimeric Therapeutics Ltd (CHM) under the Base Case is 0.985 AUD.

Is CHM stock undervalued or overvalued?

Compared with the current market price of 0.165 AUD, the stock appears Undervalued by 83%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett